Garcia Hamilton & Associates’s Pfizer PFE Stock Holding History

Garcia Hamilton & Associates’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-43,935	Closed	-$1.31M	–	71
2015 Q3	$1.31M	Sell	43,935 -36	-0.1%	-$1.15K	0.8%	48
2015 Q2	$1.4M	Sell	43,971 -5,726	-12%	-$187K	0.78%	52
2015 Q1	$1.64M	Sell	49,697 -15,195	-23%	-$483K	0.8%	51
2014 Q4	$1.92M	Sell	64,892 -27,447	-30%	-$787K	0.75%	52
2014 Q3	$2.59M	Sell	92,339 -24,112	-21%	-$677K	0.75%	51
2014 Q2	$3.28M	Buy	+116,451	New	+$3.32M	0.77%	50

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Garcia Hamilton & Associates's PFE Position: Q4 2015 in Review

Garcia Hamilton & Associates sold out of Pfizer (PFE) in Q4 2015, closing a stake of 43,935 shares — an estimated $1.31M sold.

Garcia Hamilton & Associates first reported a position in PFE in Q2 2014 and held it in 6 quarters. The position peaked at $3.28M in Q2 2014. 1,969 funds tracked by Wall St. Rank hold PFE as of Q4 2015.

Garcia Hamilton & Associates reported no remaining Pfizer position as of Q4 2015 after selling out during the quarter.
Garcia Hamilton & Associates sold 43,935 Pfizer shares in Q4 2015, an estimated $1.31M.
Garcia Hamilton & Associates first reported a position in Pfizer in Q2 2014 and held it in 6 quarters.
Garcia Hamilton & Associates's Pfizer position peaked at $3.28M in Q2 2014.
1,969 funds tracked by Wall St. Rank held Pfizer as of Q4 2015.

Based on Garcia Hamilton & Associates's 13F filing for Q4 2015, filed 8 Feb 2016.